QIAGEN N.V. (QGEN:NYSE)
$36.59 -0.05 (-0.1365%)
Analysed QIAGEN N.V. (QGEN:NYSE) News Sources
QIAGEN to advance AI-driven drug discovery with graph-based AI and curated bioinformatics knowledge with NVIDIA
19-05-2026
yahoo.com
QIAGEN and NVIDIA partner on AI drug discovery
20-05-2026
pharmaceutical-technology.com
3 Stocks in Focus That Recently Declared Dividend Hikes Amid High Inflation
20-05-2026
yahoo.com
Abbott's Biosimilar Push to Help Sustain EPD Growth Momentum
20-05-2026
yahoo.com
QIAGEN launches QIA Agent, connecting AI-driven scientific guidance across Sample to Insight workflows
20-05-2026
yahoo.com
NVIDIA Qiagen Alliance Extends AI Reach Into Drug Discovery Workflows
21-05-2026
yahoo.com
[Latest] Global Genome Editing Market Size/Share Worth USD 55.7 Billion by 2035 at a 17.4% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
21-05-2026
yahoo.com
QIAGEN Business Breakdown and Growth Drivers for 2026
28-05-2026
yahoo.com
QIAGEN Supports Infectious Disease Research and Surveillance Efforts for Bundibugyo Ebolavirus Outbreak
28-05-2026
yahoo.com
Is QGEN Stock a Hold After the 2026 Outlook Cut and Q1 Miss?
29-05-2026
yahoo.com
What is the current price of QIAGEN N.V. (QGEN:NYSE)?
The current price of QIAGEN N.V. (QGEN:NYSE) is $36.59.
QIAGEN N.V. (QGEN:NYSE) absolute price change since previous trading day?
The absolute price change of QIAGEN N.V. (QGEN:NYSE) since the previous trading day is $-0.05.
QIAGEN N.V. (QGEN:NYSE) percentage price change since previous trading day?
The percentage price change of QIAGEN N.V. (QGEN:NYSE) since the previous trading day is -0.1365%.
What is the most recent average sentiment score for QIAGEN N.V. (QGEN:NYSE)?
The most recent average sentiment score for QIAGEN N.V. (QGEN:NYSE) is 78 out of 100.
What is the most recent average sentiment for QIAGEN N.V. (QGEN:NYSE)?
The most recent sentiment for QIAGEN N.V. (QGEN:NYSE) is .
SEC-8K** Filing Available For QIAGEN N.V. (QGEN:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.